IDH1 Arg-132 mutant promotes tumor formation through down-regulating p53
IDH1 Arg-132 mutant promotes tumor formation through down-regulating p53
复制标题
IDH1 Arg-132突变体通过下调p53促进肿瘤形成
DOI:
10.1074/jbc.ra117.001385
复制
发表时间:
2018-06-22
影响因子:
4.8
通讯作者:
Li, Qinxi
中科院分区:
文献类型:
--
作者:
Jiang, Bin;Zhao, Wentao;Li, Qinxi
Resistance to apoptosis and uncontrolled proliferation are two hallmarks of cancer cells. p53 is crucial for apoptosis triggered by a broad range of stresses and a well-known gatekeeper for neoplastic transformation. Here we show that oncogenic IDH1 R132H/R132Q mutants robustly inhibit p53 expression and such an effect is attributed to 2-HG production. Mechanistically, 2-hydroxyglutarate (2-HG) stabilizes hypoxia-inducible factor-2α, which in turn activates the expression of miR-380-5p, a characterized microRNA against p53 expression. Rescue expression of p53 can inhibit the proliferation rate and impair the resistance of apoptosis induced by doxorubicin in IDH1 R132Q mouse embryonic fibroblast cells. Furthermore, p53 protein levels correlates negatively with IDH1 R132H levels in human glioma samples. Our results thus shed a new light on how p53 is down-regulated by 2-HG and suggests that impairment of p53-mediated apoptosis contributes to the tumorigenesis driven by IDH1 mutants.